Neutron Therapeutics' Accelerator Receives Final Acceptance at University of Birmingham's High Flux Accelerator-Driven Neutron Facility
![](https://mms.businesswire.com/media/20231213373335/en/1967772/4/NTI_Logo_RGB.jpg)
Neutron Therapeutics , a leading developer of accelerator-based neutron systems for targeted radiation therapy of solid tumors, today announced that its compact accelerator has received final acceptance for use at the University of Birmingham's High Flux Accelerator-Driven Neutron Facility.